776305-25-0

Basic information

• Product Name: 2-(2-{3-[1-(4-bromo-phenyl)-ethyl]-ureido}-5-ureido-pentanoylamino)-3-methyl-butyric acid
• Synonyms: 2-(2-{3-[1-(4-bromo-phenyl)-ethyl]-ureido}-5-ureido-pentanoylamino)-3-methyl-butyric acid
• CAS NO: 776305-25-0
• Molecular Weight: 500.393
• Mol File: 776305-25-0.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 2-(2-{3-[1-(4-bromo-phenyl)-ethyl]-ureido}-5-ureido-pentanoylamino)-3-methyl-butyric acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(2-{3-[1-(4-bromo-phenyl)-ethyl]-ureido}-5-ureido-pentanoylamino)-3-methyl-butyric acid(776305-25-0)
• EPA Substance Registry System: 2-(2-{3-[1-(4-bromo-phenyl)-ethyl]-ureido}-5-ureido-pentanoylamino)-3-methyl-butyric acid(776305-25-0)

Safety Data

• Hazardous Substances Data: 776305-25-0(Hazardous Substances Data)

Upstream product

• 24358-62-1 (R)-1-(4-bromophenyl)ethylamine 
• 133174-15-9 (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-5-ureidopentanoic acid 

Relevant articles and documents

Design, synthesis, and biological evaluation of peptidomimetic inhibitors of factor XIa as novel anticoagulants

Human coagulation factor XIa (FXIa), a serine protease activated by site-specific cleavage of factor XI by thrombin, FXIIa, or autoactivation, is a critical enzyme in the amplification phase of the coagulation cascade. To investigate the potential of FXIa